Acceleration 2013: Nutter Early Stage Life Sciences Conference
Monday, December 9 2013
3:30 pm – 6:30 pm
This event was posted by Nutter McClennen & Fish LLP
Location: Nutter McClennen & Fish, Louis D. Brandeis Conference Center, Seaport West, 155 Seaport Boulevard, Boston, MA 02210
Acceleration connects investors, entrepreneurs and industry executives in biotech, pharma, device and healthcare who are focused on innovation and investment for growth. Join key thought leaders to examine exit transactions and how the industry views value creation in a post-ACA world.
Healthcare: Trends in Mergers and Acquisitions
Silicon Valley Bank
Jonathan Norris will present findings from Silicon Valley Bank's annual report on healthcare venture trends, examining early stage investment, venture fundraising, exit deals, and industry forecasts.
PANEL: EXITS FOR LIFE SCIENCE COMPANIES
How the Affordable Care Act is changing the definition of value for entrepreneurs, investors and acquirers. The panel will explore the impact of the ACA -- with its focus on patient outcomes and cost control -- on the building, financing and acquisition of life science companies.
Stephen Kraus, Partner, Bessemer Venture Partners
Michael Powell, PhD, General Partner, Sofinnova Ventures
Laurel Sweeney, Sr. Director, Health Economics & Reimbursement, Philips Healthcare
Michelle L. Basil, Chair, Nutter Life Sciences Group
INTERVIEW WITH A CEO
Barbara Fox, Ph.D., Founder & CEO of Avaxia Biologics, will be interviewed by Angel investor and Board Member, Henry Kay, to describe the challenges faced, and solutions identified, in conceptualizing, funding and growing a cutting edge biotechnology company.
Program followed by cocktails & networking